SCHEMBL8038347

SCHEMBL8038347

COP(O)O[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506301 0.83
SCHEMBL65359 0.71
SCHEMBL1506405 0.69
Formaldehyde SCHEMBL29613022 0.69
SCHEMBL939695 0.69
SCHEMBL8050428 0.69
SCHEMBL10654675 0.69
SCHEMBL9113804 0.68
SCHEMBL269960 0.68
Methyl Alcohol SCHEMBL9431438 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10903522-B2 Phosphonate based lithium complexes BASF SE (DE) 2021-01-26 US disclosed
EP-3516724-B1 PHOSPHONATE BASED LITHIUM COMPLEXES BASF SE (DE) 2020-09-02 EP disclosed
US-20190252723-A1 PHOSPHONATE BASED LITHIUM COMPLEXES BASF SE (DE) 2019-08-15 US disclosed
CN-104558681-A Flame retardant and application thereof in thermal-oxidation-resistant flame-retardant nylon 6 JIANGSU HONGSHENG NEW MATERIAL CO LTD 2015-04-29 CN disclosed
EP-0563096-B1 NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES LEIRAS OY (FI) 2000-05-03 EP disclosed
US-5438048-A Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation LEIRAS OY (FI) 1995-08-01 US disclosed
EP-0563096-A1 NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES LEIRAS OY (FI) 1993-10-06 EP disclosed
WO-1992011267-A1 NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES LEIRAS OY (FI) 1992-07-09 WO disclosed